{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T17:03:34Z","timestamp":1790183014237,"version":"4.1.0"},"reference-count":59,"publisher":"Japanese Society for Magnetic Resonance in Medicine","issue":"3","funder":[{"name":"FUJIFILM Medical Co., Ltd."}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MRMS","magn reson med sci"],"published-print":{"date-parts":[[2026]]},"DOI":"10.2463\/mrms.rev.2025-0180","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T22:08:33Z","timestamp":1773871713000},"page":"n\/a","source":"Crossref","is-referenced-by-count":2,"title":["Detecting Distant Metastases in Prostate Cancer Using Whole-body MR Imaging Together with DWIBS (Diffusion-weighted Imaging with Background Body Signal Suppression)"],"prefix":"10.2463","volume":"25","author":[{"given":"Katsuyuki","family":"Nakanishi","sequence":"first","affiliation":[{"name":"Himedic Clinic Nakanoshima, Medical Corporation Himedic Clinic WEST, Osaka Osaka, Japan"},{"name":"Department of Diagnostic &amp; Interventional Radiology, Osaka International Cancer Institute, Osaka Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichiro","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Diagnostic &amp; Interventional Radiology, Osaka International Cancer Institute, Osaka Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Diagnostic &amp; Interventional Radiology, Osaka International Cancer Institute, Osaka Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keigo","family":"Yano","sequence":"additional","affiliation":[{"name":"Department of Diagnostic &amp; Interventional Radiology, Osaka International Cancer Institute, Osaka Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenari","family":"Hongyo","sequence":"additional","affiliation":[{"name":"Department of Diagnostic &amp; Interventional Radiology, Osaka International Cancer Institute, Osaka Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noboru","family":"Maeda","sequence":"additional","affiliation":[{"name":"Department of Diagnostic &amp; Interventional Radiology, Osaka International Cancer Institute, Osaka Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mio","family":"Sakai","sequence":"additional","affiliation":[{"name":"Department of Diagnostic &amp; Interventional Radiology, Osaka International Cancer Institute, Osaka Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soichiro","family":"Tateishi","sequence":"additional","affiliation":[{"name":"Department of Diagnostic &amp; Interventional Radiology, Osaka International Cancer Institute, Osaka Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiko","family":"Yamane","sequence":"additional","affiliation":[{"name":"Department of Diagnostic &amp; Interventional Radiology, Osaka International Cancer Institute, Osaka Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuo","family":"Kashiwagi","sequence":"additional","affiliation":[{"name":"Department of Diagnostic &amp; Interventional Radiology, Osaka International Cancer Institute, Osaka Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Konishi","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Osaka International Cancer Institute, Osaka Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Nagahara","sequence":"additional","affiliation":[{"name":"Department of Urology, Osaka International Cancer Institute, Osaka Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Nakayama","sequence":"additional","affiliation":[{"name":"Department of Urology, Osaka International Cancer Institute, Osaka Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Nishimura","sequence":"additional","affiliation":[{"name":"Department of Urology, Osaka International Cancer Institute, Osaka Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Takenaka","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, Osaka International Cancer Institute, Osaka Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuya","family":"Okada","sequence":"additional","affiliation":[{"name":"Iryo-hojin Jinsenkai MI Clinic, Toyonaka Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Kudo","sequence":"additional","affiliation":[{"name":"Medical Systems Research and Development Center, FUJIFILM Corporation, Ashigarakami, Kanagawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Yuzawa","sequence":"additional","affiliation":[{"name":"Medical Systems Research and Development Center, FUJIFILM Corporation, Ashigarakami, Kanagawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyuki","family":"Tomiyama","sequence":"additional","affiliation":[{"name":"Department of Diagnostic &amp; Interventional Radiology, Osaka University Graduate School of Medicine, Suita Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1295","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Ahlawat S, Debs P, Amini B, Lecouvet FE, Omoumi P, Wessell DE. Clinical applications and controversies of whole-body MRI: AJR Expert Panel Narrative Review. AJR Am J Roentgenol 2023; 220:463\u2013475.","DOI":"10.2214\/AJR.22.28229"},{"key":"2","unstructured":"2. Takahara T, Imai Y, Yamashita T, Yasuda S, Nasu S, Van Cauteren M. Diffusion weighted whole body imaging with background body signal suppression (DWIBS): Technical improvement using free breathing, STIR and high resolution 3D display. Radiat Med 2004; 22:275\u2013282."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Nakanishi K, Kobayashi M, Nakaguchi K, et al. Whole-body MRI for detecting metastatic bone tumor: Diagnostic value of diffusion-weighted images. Magn Reson Med Sci 2007; 6:147\u2013155.","DOI":"10.2463\/mrms.6.147"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Gutzeit A, Doert A, Froehlich JM, et al. Comparison of diffusion-weighted whole body MRI and skeletal scintigraphy for the detection of bone metastases in patients with prostate or breast carcinoma. Skeletal Radiol 2010; 39:333\u2013343.","DOI":"10.1007\/s00256-009-0789-4"},{"key":"5","unstructured":"5. Sun G, Zhang YX, Liu F, Tu N. Whole-body magnetic resonance imaging is superior to skeletal scintigraphy for the detection of bone metastatic tumors: A meta-analysis. Eur Rev Med Pharmacol Sci 2020; 24:7240\u20137252."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Sun W, Li M, Gu Y, Sun Z, Qiu Z, Zhou Y. Diagnostic value of whole-body DWI With background body suppression plus calculation of apparent diffusion coefficient at 3 T versus 18F-FDG PET\/CT for detection of bone metastases. AJR Am J Roentgenol 2020; 214:446\u2013454.","DOI":"10.2214\/AJR.19.21656"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Padhani AR, Makris A, Gall P, Collins DJ, Tunariu N, de Bono JS. Therapy monitoring of skeletal metastases with whole-body diffusion MRI. J Magn Reson Imaging 2014; 39:1049\u20131078.","DOI":"10.1002\/jmri.24548"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Aizawa R, Ogata T, Goto T, et al. Clinical outcomes of metastasis-directed therapy for oligo-metastatic prostate cancer diagnosed using PSMA-PET\/CT or whole-body MRI. Anticancer Res 2025; 45:2515\u20132525.","DOI":"10.21873\/anticanres.17623"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Forestieri M, Napolitano A, Tom\u00e0 P, et al. Machine learning algorithm: Texture analysis in CNO and application in distinguishing CNO and bone marrow growth-related changes on whole-body MRI. Diagnostics (Basel) 2023; 14:61.","DOI":"10.3390\/diagnostics14010061"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Algra PR, Bloem JL, Tissing H, Falke TH, Arndt JW, Verboom LJ. Detection of vertebral metastases: Comparison between MR imaging and bone scintigraphy. Radiographics 1991; 11:219\u2013232.","DOI":"10.1148\/radiographics.11.2.2028061"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Eustace S, Tello R, DeCarvalho V, et al. A comparison of whole-body turboSTIR MR imaging and planar 99mTc-methylene diphosphonate scintigraphy in the examination of patients with suspected skeletal metastases. AJR Am J Roentgenol 1997; 169:1655\u20131661.","DOI":"10.2214\/ajr.169.6.9393186"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Hargaden G, O\u2019Connell M, Kavanagh E, Powell T, Ward R, Eustace S. Current concepts in whole-body imaging using turbo short tau inversion recovery MR imaging. AJR Am J Roentgenol 2003; 180:247\u2013252.","DOI":"10.2214\/ajr.180.1.1800247"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Nakanishi K, Kobayashi M, Takahashi S, et al. Whole body MRI for detecting metastatic bone tumor: Comparison with bone scintigrams. Magn Reson Med Sci 2005; 4:11\u201317.","DOI":"10.2463\/mrms.4.11"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Huisman TA. Diffusion-weighted imaging: Basic concepts and application in cerebral stroke and head trauma. Eur Radiol 2003; 13:2283\u20132297.","DOI":"10.1007\/s00330-003-1843-6"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Stecco A, Trisoglio A, Soligo E, Berardo S, Sukhovei L, Carriero A. Whole-body MRI with diffusion-weighted imaging in bone metastases: A narrative review. Diagnostics (Basel) 2018; 8:45.","DOI":"10.3390\/diagnostics8030045"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Pearce T, Philip S, Brown J, Koh DM, Burn PR. Bone metastases from prostate, breast and multiple myeloma: Differences in lesion conspicuity at short-tau inversion recovery and diffusion-weighted MRI. Br J Radiol 2012; 85:1102\u20131106.","DOI":"10.1259\/bjr\/30649204"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Larbi A, Omoumi P, Pasoglou V, et al. Whole-body MRI to assess bone involvement in prostate cancer and multiple myeloma: comparison of the diagnostic accuracies of the T1, short tau inversion recovery (STIR), and high b-values diffusion-weighted imaging (DWI) sequences. Eur Radiol 2019; 29:4503\u20134513.","DOI":"10.1007\/s00330-018-5796-1"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Padhani AR, Lecouvet FE, Tunariu N, et al. Rationale for modernising imaging in advanced prostate cancer. Eur Urol Focus 2017; 3:223\u2013239.","DOI":"10.1016\/j.euf.2016.06.018"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Yoshida S, Takahara T, Arita Y, et al. Progressive site-directed therapy for castration-resistant prostate cancer: Localization of the progressive site as a prognostic factor. Int J Radiat Oncol Biol Phys 2019; 105:376\u2013381.","DOI":"10.1016\/j.ijrobp.2019.06.011"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Yoshida S, Takahara T, Ishii C, et al. METastasis Reporting and Data System for Prostate Cancer as a prognostic imaging marker in castration-resistant prostate cancer. Clin Genitourin Cancer 2020; 18:e391\u2013e396.","DOI":"10.1016\/j.clgc.2019.12.010"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Arita Y, Takahara T, Yoshida S, et al. Quantitative assessment of bone metastasis in prostate cancer using synthetic magnetic resonance imaging. Invest Radiol 2019; 54:638\u2013644.","DOI":"10.1097\/RLI.0000000000000579"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Pricolo P, Ancona E, Summers P, et al. Whole-body magnetic resonance imaging (WB-MRI) reporting with the METastasis Reporting and Data System for Prostate Cancer (MET-RADS-P): Inter-observer agreement between readers of different expertise levels. Cancer Imaging 2020; 20:77.","DOI":"10.1186\/s40644-020-00350-x"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Perez-Lopez R, Mateo J, Mossop H, et al. Diffusion-weighted imaging as a treatment response biomarker for evaluating bone metastases in prostate cancer: A pilot study. Radiology 2017; 283:168\u2013177.","DOI":"10.1148\/radiol.2016160646"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Lecouvet FE, Simon M, Tombal B, Jamart J, Vande Berg BC, Simoni P. Whole-body MRI (WB-MRI) versus axial skeleton MRI (AS-MRI) to detect and measure bone metastases in prostate cancer (PCa). Eur Radiol 2010; 20:2973\u20132982.","DOI":"10.1007\/s00330-010-1879-3"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Lecouvet FE, El Mouedden J, Collette L, et al. Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace Tc 99m bone scanning and computed tomography for single-step detection of metastases in patients with high-risk prostate cancer? Eur Urol 2012; 62:68\u201375.","DOI":"10.1016\/j.eururo.2012.02.020"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Shibata H, Kato S, Sekine I, et al. Diagnosis and treatment of bone metastasis: Comprehensive guideline of the Japanese Society of Medical Oncology, Japanese Orthopedic Association, Japanese Urological Association, and Japanese Society for Radiation Oncology. ESMO Open 2016; 1:e000037.","DOI":"10.1136\/esmoopen-2016-000037"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Nakanishi K, Tanaka J, Nakaya Y, et al. Whole-body MRI: Detecting bone metastases from prostate cancer. Jpn J Radiol 2022; 40:229\u2013244.","DOI":"10.1007\/s11604-021-01205-6"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Batson OV. The function of the vertebral veins and their role in the spread of metastases. Ann Surg 1940; 112:138\u2013149.","DOI":"10.1097\/00000658-194007000-00016"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Migliorini F, Maffulli N, Trivellas A, Eschweiler J, Tingart M, Driessen A. Bone metastases: A comprehensive review of the literature. Mol Biol Rep 2020; 47:6337\u20136345.","DOI":"10.1007\/s11033-020-05684-0"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Coleman R, Body JJ, Aapro M, Hadji P, Herrstedt J. Bone health in cancer patients: ESMO Clinical Practice Guidelines. Ann Oncol 2014; 25 Suppl 3:iii124\u2013iii137.","DOI":"10.1093\/annonc\/mdu103"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Macedo F, Ladeira K, Pinho F, et al. Bone metastases: An overview. Oncol Rev 2017; 11:321.","DOI":"10.4081\/oncol.2017.321"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Yamaguchi T. Intertrabecular vertebral metastases: Metastases only detectable on MR imaging. Semin Musculoskelet Radiol 2001; 5:171\u2013175.","DOI":"10.1055\/s-2001-15676"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Yamaguchi T, Tamai K, Yamato M, Honma K, Ueda Y, Saotome K. Intertrabecular pattern of tumors metastatic to bone. Cancer 1996; 78:1388\u20131394.","DOI":"10.1002\/(SICI)1097-0142(19961001)78:7<1388::AID-CNCR4>3.0.CO;2-H"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Keller ET, Zhang J, Cooper CR, et al. Prostate carcinoma skeletal metastases: Cross-talk between tumor and bone. Cancer Metastasis Rev 2001; 20:333\u2013349.","DOI":"10.1023\/A:1015599831232"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Frank JA, Ling A, Patronas NJ, et al. Detection of malignant bone tumors: MR imaging vs scintigraphy. AJR Am J Roentgenol 1990; 155:1043\u20131048.","DOI":"10.2214\/ajr.155.5.2120933"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Koh DM, Blackledge M, Padhani AR, et al. Whole-body diffusion-weighted MRI: Tips, tricks, and pitfalls. AJR Am J Roentgenol 2012; 199:252\u2013262.","DOI":"10.2214\/AJR.11.7866"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Summers P, Saia G, Colombo A, et al. Whole-body magnetic resonance imaging: Technique, guidelines and key applications. Ecancermedicalscience 2021; 15:1164.","DOI":"10.3332\/ecancer.2021.1164"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Sj\u00f6holm T, Kullberg J, Strand R, Engstr\u00f6m M, Ahlstr\u00f6m H, Malmberg F. Improved geometric accuracy of whole body diffusion-weighted imaging at 1.5T and 3T using reverse polarity gradients. Sci Rep 2022; 12:11605.","DOI":"10.1038\/s41598-022-15872-6"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Blackledge MD, Collins DJ, Tunariu N, et al. Assessment of treatment response by total tumor volume and global apparent diffusion coefficient using diffusion-weighted MRI in patients with metastatic bone disease: A feasibility study. PLoS One 2014; 9:e91779.","DOI":"10.1371\/journal.pone.0091779"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Blackledge MD, Tunariu N, Orton MR, et al. Inter- and intra-observer repeatability of quantitative whole-body, diffusion-weighted imaging (WBDWI) in metastatic bone disease. PLoS One 2016; 11:e0153840.","DOI":"10.1371\/journal.pone.0153840"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Perez-Lopez R, Tunariu N, Padhani AR, et al. Imaging diagnosis and follow-up of advanced prostate cancer: Clinical perspectives and state of the art. Radiology 2019; 292:273\u2013286.","DOI":"10.1148\/radiol.2019181931"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Padhani AR, Lecouvet FE, Tunariu N, et al. METastasis Reporting and Data System for Prostate Cancer: Practical guidelines for acquisition, interpretation, and reporting of whole-body magnetic resonance imaging-based evaluations of multiorgan involvement in advanced prostate cancer. Eur Urol 2017; 71:81\u201392.","DOI":"10.1016\/j.eururo.2016.05.033"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Parillo M, Mallio CA. The whole-body MRI reporting and data system guidelines for prostate cancer (MET-RADS-P), multiple myeloma (MY-RADS), and cancer screening (ONCO-RADS). Cancers (Basel) 2025; 17:275.","DOI":"10.3390\/cancers17020275"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Kono Y, Utsunomiya K, Nakamura S, et al. Prognostic value of whole-body diffusion-weighted imaging with background body signal suppression in CRPC patients undergoing Ra-223 therapy: An exploratory analysis. Jpn J Radiol 2025; 43:1688\u20131695.","DOI":"10.1007\/s11604-025-01817-2"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Shellock FG, Morris E, Deutsch AL, Mink JH, Kerr R, Boden SD. Hematopoietic bone marrow hyperplasia: High prevalence on MR images of the knee in asymptomatic marathon runners. AJR Am J Roentgenol 1992; 158:335\u2013338.","DOI":"10.2214\/ajr.158.2.1729795"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Poulton TB, Murphy WD, Duerk JL, Chapek CC, Feiglin DH. Bone marrow reconversion in adults who are smokers: MR imaging findings. AJR Am J Roentgenol 1993; 161:1217\u20131221.","DOI":"10.2214\/ajr.161.6.8249729"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Jung Y, Jeon SW, Kwack KS, Yun JS, Lee HD, Park S. Differentiation of vertebral metastases from focal hematopoietic marrow depositions on MRI: Added value of proton density fat fraction. AJR Am J Roentgenol 2021; 216:734\u2013741.","DOI":"10.2214\/AJR.19.22698"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Oki N, Ikebe Y, Koike H, Ideguchi R, Niino D, Uetani M. FDG-PET vs. chemical shift MR imaging in differentiating intertrabecular metastasis from hematopoietic bone marrow hyperplasia. Jpn J Radiol 2021; 39:1077\u20131085.","DOI":"10.1007\/s11604-021-01149-x"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Castagnoli F, Donners R, Tunariu N, Messiou C, Koh DM. Relative fat fraction of malignant bone lesions from breast cancer, prostate cancer and myeloma are significantly lower than normal bone marrow and shows excellent interobserver agreement. Br J Radiol 2023; 96:20230240.","DOI":"10.1259\/bjr.20230240"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Anttinen M, Ettala O, Malaspina S, et al. A prospective comparison of 18F-prostate-specific membrane antigen-1007 positron emission tomography computed tomography, whole-body 1.5 T magnetic resonance imaging with diffusion-weighted imaging, and single-photon emission computed tomography\/computed tomography with traditional imaging in primary distant metastasis staging of prostate cancer (PROSTAGE). Eur Urol Oncol 2021; 4:635\u2013644.","DOI":"10.1016\/j.euo.2020.06.012"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Deandreis D, Guarneri A, Ceci F, et al. 68Ga-PSMA-11 PET\/CT in recurrent hormone-sensitive prostate cancer (HSPC): A prospective single-centre study in patients eligible for salvage therapy. Eur J Nucl Med Mol Imaging 2020; 47:2804\u20132815.","DOI":"10.1007\/s00259-020-04809-8"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Hofman MS, Lawrentschuk N, Francis RJ, et al. Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): A prospective, randomised, multicentre study. Lancet 2020; 395:1208\u20131216.","DOI":"10.1016\/S0140-6736(20)30314-7"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53. Pyka T, Okamoto S, Dahlbender M, et al. Comparison of bone scintigraphy and 68Ga-PSMA PET for skeletal staging in prostate cancer. Eur J Nucl Med Mol Imaging 2016; 43:2114\u20132121.","DOI":"10.1007\/s00259-016-3435-0"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54. Sartor O, de Bono J, Chi KN, et al. Lutetium-177-PSMA-617 for metastatic castration-resistant prostate cancer. N Engl J Med 2021; 385:1091\u20131103.","DOI":"10.1056\/NEJMoa2107322"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55. Cattabriga A, Renzetti B, Galuppi F, et al. Multiparametric whole-body MRI: A game changer in metastatic prostate cancer. Cancers (Basel) 2024; 16:2531.","DOI":"10.3390\/cancers16142531"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56. Bhat CS, Chopra M, Andronikou S, et al. Artificial intelligence for interpretation of segments of whole body MRI in CNO: Pilot study comparing radiologists versus machine learning algorithm. Pediatr Rheumatol Online J 2020; 18:47.","DOI":"10.1186\/s12969-020-00442-9"},{"key":"57","unstructured":"57. Kumaraswamy AK, Venkategowda PB, Patil CM, et al. Automatic bone segmentation on whole-body diffusion-weighted MRI using deep learning. Proceedings of the 28th Annual Meeting of ISMRM Scientific Exhibit, Online, 2020; 2594."},{"key":"58","doi-asserted-by":"crossref","unstructured":"58. Zormpas-Petridis K, Tunariu N, Collins DJ, Messiou C, Koh DM, Blackledge MD. Deep-learned estimation of uncertainty in measurements of apparent diffusion coefficient from whole-body diffusion-weighted MRI. Comput Biol Med 2022; 149:106091.","DOI":"10.1016\/j.compbiomed.2022.106091"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59. Zormpas-Petridis K, Tunariu N, Curcean A, et al. Accelerating whole-body diffusion-weighted MRI with deep learning-based denoising image gilters. Radiol Artif Intell 2021; 3:e200279.","DOI":"10.1148\/ryai.2021200279"}],"container-title":["Magnetic Resonance in Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/mrms\/25\/3\/25_rev.2025-0180\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T05:04:16Z","timestamp":1783141456000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/mrms\/25\/3\/25_rev.2025-0180\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2463\/mrms.rev.2025-0180","relation":{},"ISSN":["1347-3182","1880-2206"],"issn-type":[{"value":"1347-3182","type":"print"},{"value":"1880-2206","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"rev.2025-0180"}}